Pfizer requests U.S. emergency use for its COVID-19 vaccine in kids aged 12-15

In March, the drugmakers said the vaccine was found to be safe, effective and produced robust antibody responses in 12- to 15-year olds in a clinical trial.

Read More

Global Radio | Worldwide Radio Station | 45000+ Radio Stations from 230+ Countries


READ:  Brazil detects 1st case of South Africa COVID-19 variant as deaths skyrocket
Back to top button